AI Summary
This article discusses new data indicating that changes in cerebrospinal fluid biomarkers associated with Alzheimer's disease can be observed up to 20 years before a clinical diagnosis. This finding could be significant for developing early prevention and therapeutic interventions for the disease.
New data on the timing of CSF biomarker changes leading to a diagnosis of Alzheimer’s disease could provide useful starting points for prevention and therapeutic strategies.
Medscape Medical News